These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37159056)

  • 21. [The first vaccine against cancer: the human papillomavirus vaccine].
    Bősze P
    Orv Hetil; 2013 Apr; 154(16):603-18. PubMed ID: 23587540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.
    Palefsky JM; Giuliano AR; Goldstone S; Moreira ED; Aranda C; Jessen H; Hillman R; Ferris D; Coutlee F; Stoler MH; Marshall JB; Radley D; Vuocolo S; Haupt RM; Guris D; Garner EI
    N Engl J Med; 2011 Oct; 365(17):1576-85. PubMed ID: 22029979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape.
    Conesa-Zamora P
    Gynecol Oncol; 2013 Nov; 131(2):480-8. PubMed ID: 23994536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
    Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus vaccines and anal carcinoma.
    Franceschi S; De Vuyst H
    Curr Opin HIV AIDS; 2009 Jan; 4(1):57-63. PubMed ID: 19339940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine.
    Namvar A; Bolhassani A; Javadi G; Noormohammadi Z
    Sci Rep; 2019 Oct; 9(1):15225. PubMed ID: 31645650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus vaccines and adolescents.
    Kahn JA; Bernstein DI
    Curr Opin Obstet Gynecol; 2005 Oct; 17(5):476-82. PubMed ID: 16141761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and clinical management of oral human papillomavirus infection in men: a series of key short messages.
    Videla S; Darwich L; Cañadas M; Clotet B; Sirera G
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):947-57. PubMed ID: 24865412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic HPV vaccination: past, present, and future.
    Castle PE; Maza M
    Epidemiol Infect; 2016 Feb; 144(3):449-68. PubMed ID: 26429676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials of human papillomavirus vaccines and beyond.
    Lehtinen M; Dillner J
    Nat Rev Clin Oncol; 2013 Jul; 10(7):400-10. PubMed ID: 23736648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention strategies against human papillomavirus in males.
    Garland SM
    Gynecol Oncol; 2010 May; 117(2 Suppl):S20-5. PubMed ID: 20138347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
    Park IU; Introcaso C; Dunne EF
    Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural and vaccine-induced B cell-derived systemic and mucosal humoral immunity to human papillomavirus.
    Mboumba Bouassa RS; Péré H; Jenabian MA; Veyer D; Meye JF; Touzé A; Bélec L
    Expert Rev Anti Infect Ther; 2020 Jun; 18(6):579-607. PubMed ID: 32242472
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune responses to human papilloma viruses.
    Stanley MA
    Indian J Med Res; 2009 Sep; 130(3):266-76. PubMed ID: 19901436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV vaccination and the effects on rates of HPV-related cancers.
    St Laurent J; Luckett R; Feldman S
    Curr Probl Cancer; 2018 Sep; 42(5):493-506. PubMed ID: 30041818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors.
    Smith JS; Backes DM; Hoots BE; Kurman RJ; Pimenta JM
    Obstet Gynecol; 2009 Apr; 113(4):917-924. PubMed ID: 19305339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope specificity and longevity of a vaccine-induced human T cell response against HPV18.
    Smith KL; Tristram A; Gallagher KM; Fiander AN; Man S
    Int Immunol; 2005 Feb; 17(2):167-76. PubMed ID: 15623547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel recombinant protein vaccine containing the different E7 proteins of the HPV16, 18, 6, 11 E7 linked to the HIV-1 Tat (47-57) improve cytotoxic immune responses.
    Mousavi T; Valadan R; Rafiei A; Abbasi A; Haghshenas MR
    Biotechnol Lett; 2021 Sep; 43(9):1933-1944. PubMed ID: 34313864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti human-papillomavirus vaccines: concepts, aims and trials].
    Bourgault-Villada I
    Rev Med Interne; 2007 Jan; 28(1):22-7. PubMed ID: 17070619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.